View Post

Gel loaded with cancer-fighting cells keeps tumors in check after surgery in mice

In Clinical Studies News by Barbara Jacoby

By: Eric Hamilton From: wisc.edu A new, biodegradable gel filled with a cocktail of immune-boosting cytokines and cancer-fighting cells staved off the growth of lingering cancer cells in mice after tumors were surgically removed. Three weeks after surgery, the tumors of mice treated with the specialized gel were roughly 60 times smaller than those of mice not given the treatment. …

View Post

Higher mushroom consumption is associated with a lower risk of cancer

In In The News by Barbara Jacoby

Source: Penn State From: sciencedaily.com Higher mushroom consumption is associated with a lower risk of cancer, according to a new study. The systematic review and meta-analysis examined 17 cancer studies published from 1966 to 2020. Analyzing data from more than 19,500 cancer patients, researchers explored the relationship between mushroom consumption and cancer risk. Next time you make a salad, you …

View Post

500,000+ Trinity Health patients affected in widespread Accellion data breach

In In The News by Barbara Jacoby

By: Anuja Vaidya From: medcitynews.com Several healthcare entities that used Accellion’s file transfer software now find themselves the victims of a data breach, including Trinity Health. The software had vulnerabilities that were exploited by cybercriminals, resulting in the exposure of personal health information. A data breach resulting from vulnerabilities in file transfer service provider Accellion’s software has affected multiple healthcare …

View Post

ICER Framework Ignores Patient Preferences, Innovation & Societal Benefits in Evaluating Cost-Effectiveness of New Cancer Treatments

In In The News by Barbara Jacoby

Policymakers Should Ban the Use of the Quality Adjusted Life Years (QALY) Methodology in Evaluating New Cancer Therapies & Prohibit ICER from Advising Government Agencies Pioneer Institute today released a new analysis, The QALY and Cancer Treatments: An Ill-Advised Match, that examines the alarming methodological and contextual shortcomings of the Quality Adjusted Life Years (QALY)-based methodology in evaluating new cancer …

View Post

Parkinson’s, cancer, type 2 diabetes share a key element that drives disease

In Clinical Studies News by Barbara Jacoby

Source: Salk Institute for Biological Studies From: prnewswire.com Enzyme with central role in cancer and type 2 diabetes also activates “clean-up” protein in Parkinson’s When cells are stressed, chemical alarms go off, setting in motion a flurry of activity that protects the cell’s most important players. During the rush, a protein called Parkin hurries to protect the mitochondria, the power …

View Post

Triage Cancer & CoPatient Partner to Help Individuals Diagnosed with Cancer Review, Manage, and Negotiate Their Medical Bills

In In The News by Barbara Jacoby

From: PR Newswire Up to 80% of medical bills have errors in them. Individuals diagnosed with cancer and their families face increased expenses for the cost of cancer care and other unexpected expenses. Ensuring that medical bills are correct before paying them is critical to avoid overpaying for medical care, and mitigating the financial burden of a cancer diagnosis. But …

View Post

Two Kinds of Acupuncture Can Relieve Pain in Cancer Survivors

In In The News by Barbara Jacoby

From: mskcc.org After a three-year clinical trial that included 360 cancer survivors — the largest of its kind to date — Memorial Sloan Kettering researchers found that two types of acupuncture significantly reduced survivors’ chronic pain. Jun Mao, Chief of the Integrative Medicine Service at MSK, explains how the results published in JAMA Oncology on March, 18, 2021, could improve …

View Post

Caris Life Sciences Study Provides First Systematic Assessment of RNA Expression of Key Molecules Involved in the Infectious Process Leading to COVID-19 in Advanced Cancer

In Clinical Studies News by Barbara Jacoby

Source: Caris Life Sciences From: PR Newswire New Data Published in Scientific Reports Reveals Possible Biological Underpinnings of Cancer Patients Hyper-Immune Response to COVID-19 Infection Patients with cancer demonstrate particularly poor outcomes from COVID-19. Caris Life Sciences®, a leading innovator in molecular science and artificial intelligence focused on fulfilling the promise of precision medicine, has published results from a study …